BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways.

Name: BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways.
Author: Yue, Peng

BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways. — المؤلف: Yue, Peng — Oncoimmunology

المؤلف: Yue, Peng
النشر: Oncoimmunology
الوصف: e1512456 p.